Deborah Baron

Director/Board Member at CEREVEL THERAPEUTICS HOLDINGS, INC.

57 year

Health Technology

Finance

Consumer Services

Profile

Deborah Baron is currently Chief Executive Officer at Amplyx Pharmaceuticals, Inc., Director at Seagen, Inc. since 2023, Independent Director at Cerevel Therapeutics Holdings, Inc. since 2021, Director at Cerevel Therapeutics, Inc., Director at Metsera, Inc. starting in 2025, and President at Encysive Pharmaceuticals, Inc. Former roles include Director at Global Blood Therapeutics, Inc., President & Director at Trillium Therapeutics, Inc., and Senior VP-Worldwide Business Development at Pfizer Inc. Education includes undergraduate studies at Massachusetts Institute of Technology and an MBA from MIT Sloan School of Management.

Deborah Baron active positions

Companies	Position	Start
CEREVEL THERAPEUTICS HOLDINGS, INC.	Director/Board Member	20/01/2021
SEAGEN INC.	Director/Board Member	14/12/2023
Amplyx Pharmaceuticals, Inc. Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines	Chief Executive Officer	-
Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies	Director/Board Member	-
Encysive Pharmaceuticals, Inc. Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases	President	-

All active positions of Deborah Baron

Former positions of Deborah Baron

Companies	Position	End
TRILLIUM THERAPEUTICS	President	-
GLOBAL BLOOD THERAPEUTICS, INC.	Director/Board Member	-
PFIZER INC.	Corporate Officer/Principal	-

See the detail of Deborah Baron's experience

Training of Deborah Baron

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Deborah Baron's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Encysive Pharmaceuticals, Inc. Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases	Health Technology
Seagen, Inc. Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases	Health Technology
Trillium Therapeutics, Inc. Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer	Health Technology
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
Amplyx Pharmaceuticals, Inc. Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines	Health Technology
Global Blood Therapeutics, Inc. Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder	Health Technology
MIT Sloan School of Management MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cerevel Therapeutics Holdings, Inc. Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders	Health Technology
Cerevel Therapeutics, Inc. Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies	Health Technology